Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Study Questions:

What is the relative safety and efficacy of dabigatran etexilate (two doses), rivaroxaban, and apixaban, compared with each other for stroke prevention in atrial fibrillation (AF)?